| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Raha Samraat S. | President and CEO, Director | 322 NORTH 2200 WEST, SALT LAKE CITY | By: Justin Hunter For: Samraat S. Raha | 02 Jun 2025 | 0001738340 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MYGN | Common Stock | Award | $5.34K | +1.5K | +0.31% | $3.56 | 483K | 31 May 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | These shares were acquired under the Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |